Inside the AI-Driven mRNA Cancer Vaccine Revolution | Sid Sijbrandij on GitLab + Biotech

Sid Sijbrandij, co-founder of GitLab, applies "founder mode" to his battle with rare bone cancer, challenging the limitations of standard clinical trials that prioritize data collection over patient outcomes. By adopting a parallel treatment strategy, he combines experimental modalities like personalized mRNA vaccines, radioligand therapies, and oncolytic viruses. Sijbrandij emphasizes the necessity of data transparency, having open-sourced 37 terabytes of his own medical records to catalyze research. He argues that the current medical system’s reliance on serial, single-drug trials creates unnecessary stasis. Instead, he advocates for patient-led, data-driven approaches that leverage AI and global collaboration to accelerate treatment development. His experience highlights the potential for "learning effects" to drastically reduce the costs and timelines of personalized medicine, transforming how rare diseases are managed and treated globally.